Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Trastuzumab deruxtecan: AstraZeneca India Pharma unveils HER-2 positive metastatic breast cancer therapy

Ruchika Sharma3 Jan 2024 3:59 PM IST

New Delhi: AstraZeneca India Pharma Ltd., a science-led biopharmaceutical company officially launched Trastuzumab deruxtecan, therapy tailored...

USFDA approvals bounce back in 2023, sparking hopes of biotech recovery

Ruchika Sharma3 Jan 2024 3:22 PM IST

The U.S. Food and Drug Administration approved nearly 50% more novel drugs in 2023 than in 2022, putting it back on pace with historical levels, an...

Novartis Loses India Patent on Heart Failure Drug Vymada

Voyager Therapeutics enters Capsid license agreement with Novartis to advance novel gene therapies

Ruchika Sharma3 Jan 2024 2:37 PM IST

Under the terms of the agreement, Novartis has agreed to pay Voyager $100 million of consideration up front, including a $20 million purchase of newly...

Boehringer Ingelheim, AnGes sign manufacturing agreement for HGF gene therapy product

Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases

Ruchika Sharma3 Jan 2024 1:53 PM IST

Ingelheim: Suzhou Ribo Life Science Co., Ltd. and Ribocure Pharmaceuticals AB (Ribo) have announced a collaboration with Boehringer Ingelheim to...

Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case

Moderna jumps on Oppenheimer upgrade, 2025 sales growth goal

Ruchika Sharma3 Jan 2024 9:00 AM IST

According to Oppenheimer, Moderna could have five products on the market by 2026.

Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for Xenpozyme

AstraZeneca-Sanofi Beyfortus gets nod for RSV disease prevention in infants in China

Ruchika Sharma2 Jan 2024 3:06 PM IST

China: AstraZeneca and Sanofi's Beyfortus (nirsevimab), a long-acting monoclonal antibody, has been approved in China for the prevention of...

Hyderabad: Spurious drugs racket busted, Rs 26 lakh stocks seized

Ruchika Sharma2 Jan 2024 1:30 PM IST

Spurious/counterfeit drugs detected and seized by DCA officials include fake medicines which are falsely labeled under the names of reputed companies...

Telangana Chief Minister A Revanth Reddy

Airport Metro, Pharma City projects not scrapped: Telangana CM

Ruchika Sharma2 Jan 2024 11:50 AM IST

Hyderabad: Telangana Chief Minister A. Revanth Reddy on Monday clarified that the state government has not scrapped the Airport Metro and Pharma...

Nephrocare India raises Rs 8.08 crore in pre-IPO round

Ruchika Sharma1 Jan 2024 1:10 PM IST

The fresh infusion of capital will fuel Nephrocare India's target of establishing 22 high-end kidney care facilities across India by March 2026.

Reckitt's Mead Johnson Nutrition recalls baby formula powder from US

Ruchika Sharma1 Jan 2024 12:12 PM IST

Reckitt Benckiser Group's Mead Johnson Nutrition (MJN) is voluntarily recalling select batches of Nutramigen Powder from the U.S. market due to a...

Cadila Pharma CMD booked for alleged rape, assault on Bulgarian woman

Ruchika Sharma1 Jan 2024 11:27 AM IST

"Following the direction of the honourable Gujarat High Court, we have registered an offence against CMD of Cadila Pharma Rajiv Modi and one more...

Alert does not reflect current situation: Indian Immunologicals on fake Abhayrab claims

Indian Immunologicals starts work on veterinary vaccine facility in Hyderabad

Ruchika Sharma31 Dec 2023 1:00 PM IST

The proposed facility has a capacity of 150 million doses per annum of FMD vaccine or FMD plus HS vaccine each.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok